Correction to: Oncogene (2006) 25, 1862–1870; doi:10.1038/sj.onc.1209236; published online 28 November 2005
The authors wish to correct the Oncogene paper cited above. In Figures 1b and d two erroneous images were provided by Dr Román-Gómez. The corrected Figures 1b and d are reprinted here in its entirety. The authors apologize to the readers, reviewers, and editors for the mistake.
ASPP1 expression and promoter methylation in ALL-derived cell lines. (b) Analysis of the mRNA expression of ASPP1 in ALL-derived cell lines and patient samples (ALL-1, ALL-2, ALL-3 and ALL-4). ALL-derived cell lines: TOM-1, LOUCY and JOURKAT. HEALTHY: peripheral blood sample of healthy donor, used as a reference control. GAPDH mRNA amplification was used to assess RNA integrity and as reference gene. (d) Analysis of ASPP1 mRNA expression in MY ALL-derived cell line after treatment with 4 mM of 5-Aza-20-deoxycytidine. GAPDH mRNA amplification was used to assess RNA integrity and as a reference gene.
Additional information
The online version of the original article can be found at 10.1038/sj.onc.1209236
Rights and permissions
About this article
Cite this article
Agirre, X., Román-Gómez, J., Jiménez-Velasco, A. et al. Erratum: ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene 32, 803 (2013). https://doi.org/10.1038/onc.2012.593
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.593
